Gene · 23705
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions. | Int J Mol Sci | 2022 | 35055096 | PubTator, text mining | PubMed |
| The Impact of Modifying Sunitinib Treatment Scheduling on Renal Cancer Tumor Biology and Resistance. | J Clin Med | 2022 | 35054064 | PubTator, text mining | PubMed |
| Who's Who? Discrimination of Human Breast Cancer Cell Lines by Raman and FTIR Microspectroscopy. | Cancers (Basel) | 2022 | 35053613 | PubTator, text mining | PubMed |
| Dynamic Intercell Communication between Glioblastoma and Microenvironment through Extracellular Vesicles. | Biomedicines | 2022 | 35052830 | PubTator, text mining | PubMed |
| Targeting PI3K by Natural Products: A Potential Therapeutic Strategy for Attention-deficit Hyperactivity Disorder. | Curr Neuropharmacol | 2022 | 35043762 | PubTator, text mining | PubMed |
| Integrated genome and transcriptome analyses reveal the mechanism of genome instability in ataxia with oculomotor apraxia 2. | Proc Natl Acad Sci U S A | 2022 | 35042798 | PubTator, text mining | PubMed |
| Poster Presentations - Abstracts of the 25th Annual Congress of the SBRA and the 15th REDLARA Taller General Rio de Janeiro/RJ - Brazil, 2021. | JBRA Assist Reprod | 2022 | 35040307 | PubTator, text mining | PubMed |
| The genetics of glaucoma: Disease associations, personalised risk assessment and therapeutic opportunities-A review. | Clin Exp Ophthalmol | 2022 | 35037362 | PubTator, text mining | PubMed |
| Persistent coxsackievirus B1 infection triggers extensive changes in the transcriptome of human pancreatic ductal cells. | iScience | 2022 | 35024587 | PubTator, text mining | PubMed |
| Role and Involvement of TENM4 and miR-708 in Breast Cancer Development and Therapy. | Cells | 2022 | 35011736 | PubTator, text mining | PubMed |
| Subsets of cancer cells expressing CX3CR1 are endowed with metastasis-initiating properties and resistance to chemotherapy. | Oncogene | 2022 | 34999735 | PubTator, text mining | PubMed |
| Common Genomic Aberrations in Mouse and Human Breast Cancers with Concurrent P53 Deficiency and Activated PTEN-PI3K-AKT Pathway. | Int J Biol Sci | 2022 | 34975329 | PubTator, text mining | PubMed |
| DNA hypermethylation of CADM1, PAX5, WT1, RARβ, and PAX6 genes in oropharyngeal cancer associated with human papillomavirus. | Epigenetics | 2022 | 34974810 | PubTator, text mining | PubMed |
| Investigation of small molecule inhibitors of the SARS-CoV-2 papain-like protease by all-atom microsecond modelling, PELE Monte Carlo simulations, and in vitro activity inhibition. | Chem Phys Lett | 2022 | 34961797 | PubTator, text mining | PubMed |
| Proteomic analysis and miRNA profiling of human testicular endothelial cell-derived exosomes: the potential effects on spermatogenesis. | Asian J Androl | 2022 | 34916478 | PubTator, text mining | PubMed |
| Nephrotoxicity evaluation of 3-monochloropropane-1,2-diol exposure in Sprague-Dawley rats using data-independent acquisition-based quantitative proteomics analysis. | Toxicol Lett | 2022 | 34915118 | PubTator, text mining | PubMed |
| Differential fates of introns in gene expression due to global alternative splicing. | Hum Genet | 2022 | 34907472 | PubTator, text mining | PubMed |
| Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer. | Clin Cancer Res | 2022 | 34907082 | PubTator, text mining | PubMed |
| Diversity of human NK cell developmental pathways defined by single-cell analyses. | Curr Opin Immunol | 2022 | 34861544 | PubTator, text mining | PubMed |
| Mechanisms of Mast Cell Activation in Severe Asthma: Beyond IgE. | Am J Respir Crit Care Med | 2022 | 34856107 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23705/papers?page=43